<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Carlton EW</submitter><funding>Royal College of Emergency Medicine</funding><funding>Emergency Care Foundation, New Zealand</funding><funding>Queensland Emergency Medicine Research Foundation</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Canterbury Medical Research Foundation</funding><pagination>665-672</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5890641</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>104(8)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>We aimed to evaluate the limit of detection of high-sensitivity troponin (hs-cTn) and Thrombolysis In Myocardial Infarction (TIMI) score combination rule-out strategy suggested within the 2016 National Institute for Health and Care Excellence (NICE) Chest Pain of Recent Onset guidelines and establish the optimal TIMI score threshold for clinical use.&lt;h4>Methods&lt;/h4>A pooled analysis of adult patients presenting to the emergency department with chest pain and a non-ischaemic ECG, recruited into six prospective studies, from Australia, New Zealand and the UK. We evaluated the sensitivity of TIMI score thresholds from 0 to 2 alongside hs-cTnT or hs-cTnI for the primary outcome of major adverse cardiac events within 30 days.&lt;h4>Results&lt;/h4>Data were available for 3159 patient</pubmed_abstract><journal>Heart (British Cardiac Society)</journal><pubmed_title>Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy.</pubmed_title><pmcid>PMC5890641</pmcid><funding_grant_id>PDF-2012-05-193</funding_grant_id><pubmed_authors>Pickering JW</pubmed_authors><pubmed_authors>Than M</pubmed_authors><pubmed_authors>Parsonage WA</pubmed_authors><pubmed_authors>Greaves K</pubmed_authors><pubmed_authors>Cullen L</pubmed_authors><pubmed_authors>Khattab A</pubmed_authors><pubmed_authors>Greenslade J</pubmed_authors><pubmed_authors>Kendall J</pubmed_authors><pubmed_authors>Carlton EW</pubmed_authors><pubmed_authors>Body R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy.</name><description>&lt;h4>Objective&lt;/h4>We aimed to evaluate the limit of detection of high-sensitivity troponin (hs-cTn) and Thrombolysis In Myocardial Infarction (TIMI) score combination rule-out strategy suggested within the 2016 National Institute for Health and Care Excellence (NICE) Chest Pain of Recent Onset guidelines and establish the optimal TIMI score threshold for clinical use.&lt;h4>Methods&lt;/h4>A pooled analysis of adult patients presenting to the emergency department with chest pain and a non-ischaemic ECG, recruited into six prospective studies, from Australia, New Zealand and the UK. We evaluated the sensitivity of TIMI score thresholds from 0 to 2 alongside hs-cTnT or hs-cTnI for the primary outcome of major adverse cardiac events within 30 days.&lt;h4>Results&lt;/h4>Data were available for 3159 patient</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2026-07-15T21:27:49.896Z</modification><creation>2026-07-09T10:14:24.305Z</creation></dates><accession>S-EPMC5890641</accession><cross_references><pubmed>28864718</pubmed><doi>10.1136/heartjnl-2017-311983</doi></cross_references></HashMap>